" CURAIZON "
sell its compliance solutions to national health services worldwide.
We solve real-world problems by helping patients take their medications properly
Every day, millions of people fail to take their medication as determined and the resulting personal and financial costs are staggering. Worldwide, noncompliance generates $ 700 billion in medical costs that can be avoided.
The data we create are unique and have tremendous value for pharmaceutical companies, researchers, and governments.
Whenever a patient uses our CuraServe technology, our data grows in utility and value.
Curaizon ™ solves the problem of drug disobedience by spreading our technology through national health services. As part of our solution, we collect full anonymous data about how and when patients take medication.
CuraTokens ™ is the only way to access our data. Tokens may be redeemed for data access, which will advance medical research, lower health care costs and save lives.
The value of CuraToken ™ is based on real solutions to real problems.
Play videos and learn more about Curaizon ™
What does the company do?
We aim to improve drug adherence and bring benefits that change the game for patients and healthcare providers by becoming the leading supplier of compliance and data solutions worldwide.
What's unique about the company?
Our solutions work with patients, their families, and health care providers to ensure that patients take their medication as prescribed through a range of outreach tools, supported by predictive modeling tools and behavioral analysis, to improve drug compliance rates.
What problem does the company solve?
Our CuraServe technology helps ensure that patients take their medication as prescribed by their doctor. By doing this, we help patients live longer and healthier lives. We also reduce the cost of health care that occurs when patients fail to take their medication properly.
How do you create value to support your CuraTokens?
Our CuraServe ™ technology generates large amounts of unique and real-time data showing how people use their most valuable medicines for various groups including pharmaceutical companies, medical researchers, and biotech companies. CuraTokens ™ allows the token owner to access data to create queries. When our solution was launched to more patients in more countries. The more data we generate, the more valuable that CuraTokens ™ becomes.
Who is your target customer?
Curaizon ™ sells its compliance solutions (CuraServe ™) to national health services worldwide. Our end users are health care patients who take any form of medicine. We also work with industry, pharmaceutical and biotechnology academics, as well as other data users through our CuraData ™ solution.
What is your geographic target market?
Curaizon targets countries with national health services. It currently includes 1.4 billion people and that number is growing.
What is the market potential?
The cost of global non-compliance is over € 600 billion annually and generates hundreds of thousands of lives lost prematurely. Adherence to chronic and long-term diseases is less than 50%.
Curaizon ™ ecosystem
CuraToken ™ Utility Tokens (CTKN) allows token holders to access our exclusive and anonymous medical data in blockchain.
CuraTokens ™ is the only way to access Curaizon ™ technology.
CuraToken ™ holders can access data that uses strong analytics, predictions, AI and large data in the war against drug noncompliance.
CuraTokens ™ provides real-time analysis of patient behavior and compliance.
CuraTokens ™ allows the use of blockchain technology to manage authentication, confidentiality and accountability by allowing individuals to control their data, providing protection, security, and compliance with all necessary regulations, including GDPR.
CuraTokens ™ facilitates partnerships with medical and pharmaceutical organizations through a token reward system.
The holders of CuraToken ™ know that they save lives around the world by helping solve the problem of drug non-compliance.
January 2016
Development of CuraServe ™ Starts
June 2017
The CuraServe ™ test takes place
February 2018
Full Alpha CuraData ™ release
June 1, 2018
Start Token Presale
June 8, 2018
Token Public Sale Begins
November 2018
Full CuraData ™ Beta Release
March 2019
CuraServe ™ Public Release
July 2019
Growing CuraData ™ Platform
2020
Release Curadata ™ 2.0
Our team combines passion, innovation, and expertise with experience in health, finance, operations, marketing, and technology
LEADERSHIP
BUSINESS DEVELOPMENT
TECHNOLOGY
IcoBox
ICO Campaign Partners
ICOBox is the first and largest new generation of Promoters of Blokchain Builders and Business Facilitators for companies that want to sell their products through ICO crowdsales.
Gateway Technolabs
Software development
Global information technology services, solutions, and product engineering companies with a team of dedicated and professional professionals who serve our customers in 30 countries across 5 continents.
Innohead
Large Data & Predictive Analysis
Big Data and Predictive Analytics companies focus on data mining and customer analytics.
Timengo
IoT, Cloud, and security experts
Timengo is an expert on IoT, Cloud, and security with a wealth of knowledge and experience in the health care sector. They encourage our internal and external application technologies and help us to deliver secure API infrastructure with external databases.
CLX
CPaaS Tier-1 Provider
CLX is the only provider of CPaaS tier-1 that is trusted to carry over 25 billion transactions per year and is our notification partner.
ADVISORS
For more information link below:
Website: https://curatoken.curaizon.com/
Telegram: https://t.me/joinchat/ILiK_Q7VBLOByz_7mMUgsQ
Ann Thread: https://bitcointalk.org/index.php?topic=4401662.0
Twitter: https://twitter.com/curaizon
Funmilola
Bitcointalk profile link: https://bitcointalk.org/index.php?action=profile;u=1235825